N = 167 | ||
---|---|---|
Variables (n, % of missing data) | N | % (n) or median (IQR) |
Male sex | 167 | 45.5 (76) |
Infant group at inclusion | 167 | |
Followed since birth | 37.7 (63) | |
Not followed since birth but diagnosed before age 7 months | 62.3 (130) | |
Recruitment sites | 167 | |
CME/FCB | 47.3 (79) | |
HLD | 23.4 (39) | |
CHE | 29.3 (49) | |
History of breastfeeding | 110 | 51.8 (57) |
Vital status of parents at cART initiation | 167 | |
Mother dead | 6.6 (11) | |
Father dead | 3.6 (6) | |
Vital status of the father unknown (or data missing) | 6.6 (11) | |
Infants living with: | 167 | |
Both parents | 50.3 (84) | |
Mother only | 37.7 (63) | |
Other caregivers | 12.0 (20) | |
Presence of functional fridge at home | 115 | 43.5 (50) |
Difficulty with remembering to give cART medication | ||
M3 | 138 | 33.3 (46) |
M12 | 123 | 24.4 (30) |
M24 | 81 | 29.6 (24) |
Clinical status at cART initiation | 167 | |
WAZ (median, IQR) | −0.2 (−0.4; −0.1) | |
History of hospitalization | 41.3 (69) | |
CD4 count (%) at cART initiation (median, IQR) | 161 | 23 (15 ; 32) |
Viral load at cART initiation (log10 cp/mL) (median, IQR) | 166 | 6.5 (6.0 ; 6.9) |
Age at cART initiation | 167 | |
< 6 months | 80.8 (135) | |
6–12 months | 16.8 (28) | |
> 12 months | 2.4 (4) | |
In months (median, IQR) | 4.0 (3.0–9.0) | |
Type of first cART | 167 | |
Protease inhibitor-based regimen | 63.9 (110) | |
Nevirapine-based regimen | 34.1 (57) |